单细胞分析市场规模、份额、成长分析，按类型、应用、地区划分 - 产业预测，2024-2031 年

2022年全球单细胞分析市场规模为32亿美元，从2023年的36.3亿美元成长到2031年的100亿美元，预计复合年增长率为13.50%。

全球单细胞分析市场正在经历强劲成长，预计在不久的将来将进一步扩大。该领域在癌症研究、免疫学、神经科学和干细胞生物学等多个研究领域中变得越来越重要。这一增长的主要驱动力是对个人化医疗的需求不断增长。基因组学和分子生物学的进展强调，组织和生物体内的单一细胞可以表现出各种不同的特征和反应。这种认识正在推动向标靶治疗和精准医学的转变，其中分析单细胞可以为为个别患者量身定制治疗提供重要的见解。检查单一细胞的能力有助于识别疾病特异性生物标记、了解疾病进展并开发有效的治疗方法。因此，市场对单细胞分析技术和解决方案的需求不断增加。流式细胞技术、次世代定序、质谱流式细胞仪和单细胞 PCR 等技术透过实现细胞特性和功能的高分辨率分析，正在彻底改变该领域，进一步推动市场扩张。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

单细胞分析市场：按产品

• 市场概况
• 消耗品
  • 珠子、微孔盘
  • 试剂
  • 检测试剂套件
  • 免疫检测
  • 基于细胞的检测
  • 其他消耗品
• 装置
  • 流式细胞仪
  • NGS系统
  • PCR设备
  • 光强度
  • 细胞计数器
  • 显微镜
  • HCS系统
  • 微阵列
  • 其他乐器

单细胞分析市场：依细胞类型

• 市场概况
• 人体细胞
• 动物细胞
• 微生物细胞

单细胞分析市场：依方法分类

• 市场概况
• 流式细胞技术
• 次世代定序
• 聚合酵素链锁反应
• 显微镜检查
• 质谱分析
• 其他技术

单细胞分析市场：依应用分类

• 市场概况
• 研究用途
  • 癌症研究
  • 免疫学研究
  • 神经学研究
  • 干细胞研究
  • 其他研究用途
• 医疗用途
  • 非侵入性产前诊断
  • 体外受精
  • 循环性肿瘤细胞的检测

单细胞分析市场：依最终用户分类

• 市场概况
• 学术研究所
• 生物技术和製药公司
• 医院和诊断实验室
• 细胞库和IVF中心

单细胞分析市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• BD（US）
• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• 10x Genomics（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• Qiagen（Germany）
• Illumina, Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Diasorin SPA（Italy）
• Standard Biotools（US）
• Tecan Trading AG（Switzerland）
• Sartorius AG（Germany）
• Corning Incorporated（US）
• Cytek Biosciences（US）
• Takara Bio Inc.（Japan）
• Biomerieux（France）
• Revvity（US）
• Bio-Techne（US）
• Pacbio（US）
• Bruker（US）
• Promega Corporation（US）
• Oxford Nanopore Technologies Plc（UK）
• Singleron Biotechnologies（China）
• Cell Microsystems（US）
• Nanocellect Biomedical（US）
• Rarecyte, Inc.（US）
• Bico（Sweden）
• Menarini Group（Italy）

Global Single Cell Analysis Market size was valued at USD 3.20 billion in 2022 and is poised to grow from USD 3.63 billion in 2023 to USD 10.00 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The global market for single-cell analysis is experiencing robust growth and is set for further expansion in the near future. This field is becoming increasingly significant across various research areas including cancer research, immunology, neuroscience, and stem cell biology. A major driver of this growth is the rising demand for personalized medicine. Advances in genomics and molecular biology have highlighted that individual cells within a tissue or organism can display a range of distinct characteristics and responses. This realization is pushing the shift towards targeted therapies and precision medicine, where analyzing single cells provides critical insights for customizing treatments to individual patients. The ability to examine individual cells has been instrumental in identifying disease-specific biomarkers, understanding disease progression, and developing effective therapies. As a result, there is a growing market demand for single-cell analysis technologies and solutions. Techniques such as flow cytometry, next-generation sequencing, mass cytometry, and single-cell PCR have transformed the field by enabling high-resolution analysis of cellular characteristics and functions, further fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Cell Analysis Market Segmental Analysis

Global Single Cell Analysis Market is segmented by Product, Cell Type, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, Animal Cells, and Microbial Cells. Based on Technique, the market is segmented into Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, and Other Techniques. Based on Application, the market is segmented into Research Applications, Medical Applications. Based on End User, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Single Cell Analysis Market

Stem cell biology is undergoing a major research boost due to the promising therapeutic potential of stem cells. Single-cell analysis is crucial in this field as it allows for the detailed characterization and manipulation of stem cells at the individual cell level. This approach enables researchers to identify and isolate specific stem cell populations, monitor their differentiation processes, and assess their functional attributes. As interest in stem cell biology grows, there is an increasing demand for sophisticated single-cell analysis tools and technologies to support these advancements.

Restraints in the Global Single Cell Analysis Market

Single-cell analysis faces significant challenges due to its inherent complexity and high costs. The techniques involved often demand specialized equipment, skilled operators, and meticulously defined workflows, which can complicate their implementation. This complexity can limit the widespread adoption of single-cell analysis, especially in resource-constrained environments where advanced infrastructure and expertise are scarce. Additionally, the financial burden associated with acquiring and maintaining the necessary equipment and reagents for single-cell analysis can be prohibitive for smaller research labs and institutions. These cost and complexity issues create barriers that need to be addressed to make single-cell analysis more accessible and affordable across diverse research settings.

Market Trends of the Global Single Cell Analysis Market

A notable trend in the single-cell analysis market is the growing adoption of spatial transcriptomics. This advanced technique enables researchers to visualize and analyze gene expression patterns across entire tissues, providing valuable insights into cellular organization. By mapping gene activity in situ, spatial transcriptomics helps identify various cell types and subtypes, as well as elucidate cellular interactions within their native environments. This approach enhances our understanding of tissue architecture and cellular dynamics, offering a deeper perspective on how cells communicate and function collectively. As a result, spatial transcriptomics is becoming increasingly integral to research efforts aimed at unraveling complex biological processes and disease mechanisms.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Single Cell Analysis Market by Product

• Market Overview
• Consumables
  • Beads, Microplates
  • Reagents
  • Assay Kits
  • Immunoassays
  • Cell-Based Assays
  • Other Consumables
• Instruments
  • Flow Cytometers
  • NGS Systems
  • PCR Instruments
  • Spectrophotometers
  • Cell Counters
  • Microscopes
  • HCS Systems
  • Microarrays
  • Other Instruments

Single Cell Analysis Market by Cell Type

• Market Overview
• Human Cells
• Animal Cells
• Microbial Cells

Single Cell Analysis Market by Technique

• Market Overview
• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
• Other Techniques

Single Cell Analysis Market by Application

• Market Overview
• Research Applications
  • Cancer Research
  • Immunology Research
  • Neurology Research
  • Stem Cell Research
  • Other Research Applications
• Medical Applications
  • Non-Invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection

Single Cell Analysis Market by End User

• Market Overview
• Academic & Research Laboratories
• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Cell Banks & IVF Centers

Single Cell Analysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin S.P.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Biotools (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytek Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacbio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singleron Biotechnologies (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Microsystems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanocellect Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rarecyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bico (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments